{"i":{"7":{"name":"1 salmeterol/fluticasone propionate","spans":[{"i":"4892","f":"4925","txt":"salmeterol/fluticasone propionate"},{"i":"4927","f":"4930","txt":"SFC"},{"i":"5206","f":"5219","txt":"SFC 50/250 µg"},{"i":"5386","f":"5389","txt":"SFC"},{"i":"5568","f":"5571","txt":"SFC"},{"i":"6178","f":"6181","txt":"SFC"},{"i":"6559","f":"6562","txt":"SFC"},{"i":"-1","f":"-1","txt":"Fluticasone propionate + salmeterol"}]},"16":{"name":"2 salmeterol","spans":[{"i":"4936","f":"4946","txt":"salmeterol"},{"i":"4948","f":"4951","txt":"SAL"},{"i":"5223","f":"5232","txt":"SAL 50 µg"},{"i":"5397","f":"5400","txt":"SAL"},{"i":"5660","f":"5663","txt":"SAL"},{"i":"6032","f":"6035","txt":"SAL"},{"i":"6189","f":"6192","txt":"SAL"},{"i":"-1","f":"-1","txt":"Salmeterol"}]}},"o":{"24":{"name":"1 moderate/severe exacerbation rates","spans":[{"i":"4983","f":"5017","txt":"moderate/severe exacerbation rates"},{"i":"5428","f":"5465","txt":"rate of moderate/severe exacerbations"},{"i":"5605","f":"5642","txt":"rate of moderate/severe exacerbations"},{"i":"5982","f":"6019","txt":"rate of moderate/severe exacerbations"},{"i":"-1","f":"-1","txt":"Moderate/severe exacerbations (overall)"}]},"37":{"name":"2 receiving diuretics","spans":[{"i":"5758","f":"5777","txt":"receiving diuretics"},{"i":"6203","f":"6222","txt":"receiving diuretics"},{"i":"6354","f":"6373","txt":"receiving diuretics"},{"i":"-1","f":"-1","txt":"Moderate/severe exacerbations (when receiving diuretics) "}]},"44":{"name":"3 forced expiratory volume in 1 s (FEV1) reversibility ≥12%","spans":[{"i":"5840","f":"5914","txt":"forced expiratory volume in 1 s (FEV1) reversibility ≥12%"},{"i":"6417","f":"6451","txt":"FEV1 reversibility >12%"},{"i":"-1","f":"-1","txt":"Moderate/severe exacerbations (when FEV1 reversibility ≥12%) "}]},"47":{"name":"4 not receiving diuretics and without FEV1 reversibility","spans":[{"i":"6077","f":"6145","txt":"not receiving diuretics and without FEV1 reversibility"},{"i":"-1","f":"-1","txt":"Moderate/severe exacerbations (no diuretics nor FEV1 reversibility) "}]},"50":{"name":"5 reduction in COPD-associated exacerbations","spans":[{"i":"6511","f":"6553","txt":"reduction in COPD-associated exacerbations"}]}}}